Witnessing the stock’s movement on the chart, on Wednesday, Tandem Diabetes Care Inc (NASDAQ: TNDM) set off with pace as it heaved 3.62% to $15.75, before settling in for the price of $15.2 at the close. Taking a more long-term approach, TNDM posted a 52-week range of $14.87-$48.24.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company of the Healthcare sector’s yearbook sales growth during the past 5- year span was recorded -28.23%. Meanwhile, its Annual Earning per share during the time was -28.23%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 6.17%. This publicly-traded company’s shares outstanding now amounts to $66.57 million, simultaneously with a float of $65.97 million. The organization now has a market capitalization sitting at $1.05 billion. At the time of writing, stock’s 50-day Moving Average stood at $20.05, while the 200-day Moving Average is $27.28.
Tandem Diabetes Care Inc (TNDM) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Medical Devices industry. Tandem Diabetes Care Inc’s current insider ownership accounts for 0.96%, in contrast to 110.39% institutional ownership. According to the most recent insider trade that took place on Mar 07 ’25, this organization’s EVP & Chief Operating Officer bought 10,538 shares at the rate of 18.12, making the entire transaction reach 190,966 in total value, affecting insider ownership by 10,538. Preceding that transaction, on Nov 21 ’24, Company’s Director sold 30,000 for 31.38, making the whole transaction’s value amount to 941,400. This particular insider is now the holder of 165,190 in total.
Tandem Diabetes Care Inc (TNDM) Earnings and Revenue Records
Tandem Diabetes Care Inc’s EPS increase for this current 12-month fiscal period is 6.17% and is forecasted to reach -0.64 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 71.44% through the next 5 years, which can be compared against the -28.23% growth it accomplished over the previous five years trading on the market.
Tandem Diabetes Care Inc (NASDAQ: TNDM) Trading Performance Indicators
Let’s observe the current performance indicators for Tandem Diabetes Care Inc (TNDM). It’s Quick Ratio in the last reported quarter now stands at 1.81. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 1.07.
In the same vein, TNDM’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -2.78, a figure that is expected to reach -0.40 in the next quarter, and analysts are predicting that it will be -0.64 at the market close of one year from today.
Technical Analysis of Tandem Diabetes Care Inc (TNDM)
Going through the that latest performance of [Tandem Diabetes Care Inc, TNDM]. Its last 5-days volume of 1.73 million indicated improvement to the volume of 1.57 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 22.50% While, its Average True Range was 31.90%.
Raw Stochastic average of Tandem Diabetes Care Inc (TNDM) in the period of the previous 100 days is set at 4.35%, which indicates a major fall in contrast to 18.92% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.89 that was lower than 1.10 volatility it exhibited in the past 100-days period.
